BROAD EFFECTIVENESS TRIAL; ANTIPSYCHOTIC MEDICATIONS; PSYCHIATRIC PRACTICE; WEIGHT-GAIN; OPEN-LABEL; PLACEBO; MULTICENTER; SAFETY; HALOPERIDOL; MANAGEMENT
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, v.24, no.4, pp.181 - 188
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.